FGF14
protein-codingfibroblast growth factor 14, the group of MicroRNA protein coding host genes|Fibroblast growth factor family
Gene summary
The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. A mutation in this gene is associated with autosomal dominant cerebral ataxia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~691.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0012247
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0012247
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0015244
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0012247
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0008654
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FGF14 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004115.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 25 | 2 | 31 | ||
| missense | 2 | 60 | 7 | 69 | ||
| nonsense | 3 | 2 | 5 | |||
| start loss | 0 | |||||
| frameshift | 2 | 6 | 8 | |||
| splice donor/acceptor (+/-2bp) | 1 | 3 | 4 | |||
| Total | 8 | 9 | 66 | 32 | 2 | 117 |
Highest pathogenic variant AF is 6.887698e-7
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004106.1 | 5 | MANE Select | |
| Ensembl | ENSP00000365313.4 | 5 | MANE Select | |
| RefSeq | NP_001308860.1 | 4 | Standard | |
| RefSeq | NP_001308861.1 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- MAPK Signaling Pathway
- ESC Pluripotency Pathways
- Focal Adhesion-PI3K-Akt-mTOR-signaling pathway
- PI3K-Akt Signaling Pathway
- Regulation of Actin Cytoskeleton
Biological Process
- signal transduction
- cell-cell signaling
- nervous system development
- regulation of signaling receptor activity
- regulation of synaptic plasticity
Molecular Function
- protein binding
- growth factor activity
Cellular Component
- extracellular region
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000376131
- Coding exons
- 5
- Length
- 681991
- Individuals with no LoFs
- 125715
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 2
- Defined
- 125717
- p
- 0.00000795
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.76 | 75 | 132 | 0.568 | 0.00000644 | 1650 |
| Missense (PolyPhen) | 4 | 32.777 | 0.12204 | 419 | ||
| Synonymous | 0.264 | 48 | 50.4 | 0.953 | 0.00000261 | 462 |
| Loss of Function | 2.96 | 1 | 12.1 | 0.0826 | 5.96e-7 | 158 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000018 | 0.000018 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Probably involved in nervous system development and function.;
Recessive Scores
- pRec
- 0.171
Intolerance Scores
- LoFtool
- 0.236
- RVIS EVS
- -0.01
- RVIS percentile EVS
- 53.51
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.352
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |